Bright Minds Biosciences (DRUG) has had the highest return since June 23, 2024 by a small-cap US stock, returning 7,958.3%.
| ASSET | % RETURN |
|---|---|
Bright Minds Biosciences (DRUG) | 7,958.25% |
Nutex Health (NUTX) | 2,610.38% |
United States Antimony (UAMY) | 2,397.98% |
Monopar Therapeutics (MNPR) | 1,875.28% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 1,874.72% |
Red Cat (RCAT) | 1,285.58% |
Unusual Machines (UMAC) | 1,074.21% |
Corvus Pharmaceuticals (CRVS) | 1,069.95% |
Trilogy Metals (TMQ) | 1,048.07% |
Power Solutions International, Inc Common Stock (PSIX) | 1,032.47% |
LightPath Technologies (LPTH) | 1,020% |
Palvella Therapeutics (PVLA) | 989% |
Kodiak Sciences (KOD) | 901.5% |
Almonty Industries Inc Common Shares (ALM) | 845.04% |
Amylyx Pharmaceuticals (AMLX) | 819.44% |
Amprius Technologies (AMPX) | 779.53% |
Zepp Health (ZEPP) | 724.64% |
Nova Minerals (NVA) | 671.67% |
Aeva Technologies, Inc Common Stock (AEVA) | 659.23% |
Personalis (PSNL) | 651.2% |
Avino Silver & Gold Mines (ASM) | 614.29% |
Lightbridge (LTBR) | 600.82% |
DeFi Development (DFDV) | 600.22% |
Northern Dynasty Minerals (NAK) | 589.19% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 585.23% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
